Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · IEX Real-Time Price · USD
27.51
+0.49 (1.81%)
At close: Mar 28, 2024, 4:00 PM
28.00
+0.49 (1.78%)
After-hours: Mar 28, 2024, 7:34 PM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $2.65 billion as of March 28, 2024. Its market cap has decreased by -18.85% in one year.
Market Cap
2.65B
Enterprise Value
1.86B
1-Year Change
-18.85%
Ranking
Category
Stock Price
$27.51
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $2.65B, an increase of 250.30%. That is a compound annual growth rate of 17.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 2.64B | 1.81% |
Mar 27, 2024 | 2.60B | 2.89% |
Mar 26, 2024 | 2.52B | -2.12% |
Mar 25, 2024 | 2.58B | -0.30% |
Mar 22, 2024 | 2.59B | -2.68% |
Mar 21, 2024 | 2.66B | -0.47% |
Mar 20, 2024 | 2.67B | 0.54% |
Mar 19, 2024 | 2.66B | 0.95% |
Mar 18, 2024 | 2.63B | -3.29% |
Mar 15, 2024 | 2.72B | 2.84% |
Mar 14, 2024 | 2.64B | -4.01% |
Mar 13, 2024 | 2.76B | 3.21% |
Mar 12, 2024 | 2.67B | -5.96% |
Mar 11, 2024 | 2.84B | -1.43% |
Mar 8, 2024 | 2.88B | -0.17% |
Mar 7, 2024 | 2.89B | 0.23% |
Mar 6, 2024 | 2.88B | -0.99% |
Mar 5, 2024 | 2.91B | -6.61% |
Mar 4, 2024 | 3.11B | -0.83% |
Mar 1, 2024 | 3.14B | 1.68% |
Feb 29, 2024 | 3.09B | -2.07% |
Feb 28, 2024 | 3.15B | 5.74% |
Feb 27, 2024 | 2.98B | 12.15% |
Feb 26, 2024 | 2.66B | 5.98% |
Feb 23, 2024 | 2.51B | -3.97% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Integra LifeSciences Holdings | 2.64B |
Summit Therapeutics | 2.63B |
Corcept Therapeutics | 2.62B |
Premier | 2.61B |
Merus | 2.61B |
Teladoc Health | 2.54B |
Alpine Immune Sciences | 2.53B |
Rhythm Pharmaceuticals | 2.51B |